09.12.2009 • News

Cognis Q1 Results 2009

In the first three months of 2009 Cognis saw its sales volumes decline by about 18 % in comparison to the Q1 of 2008. Compared with the Q4 of 2008 volumes actually increased by 5 %, driven by growth in North America and Asia. Cognis' operating result (adjusted Ebitda) fell by 19.3 % to €73 million. Return on sales (adjusted Ebitda as a percentage of sales) for the Q1 was 11 %. EBIT decreased by €21 million to €35 million. The company made a net loss including exceptional items of €33 million for the period (minus €43 million). Operating cash flow in the period improved significantly and was up by €95 million to €101 million. Overall, Cognis' cash position increased substantially, to €241 million.

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.